Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$8.20 USD
+0.15 (1.81%)
Updated Mar 27, 2024 03:18 PM ET
After-Market: $8.24 +0.04 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-3.09 | 6.96% |
Earnings Summary
For their last quarter, Oncternal Therapeutics (ONCT) reported earnings of -$3.11 per share, missing the Zacks Consensus Estimate of -$3.09 per share. This reflects a negative earnings surprise of 0.65%. Look out for ONCT's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$3.09 per share, reflecting a year-over-year increase of 22.75%.
Earnings History
Price & Consensus
Zacks News for ONCT
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
ONCT: What are Zacks experts saying now?
Zacks Private Portfolio Services